These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. A girl with rickets and nephrocalcinosis. Godefroid N; Proesmans W Pediatr Nephrol; 2003 Jun; 18(6):573-5. PubMed ID: 12720081 [TBL] [Abstract][Full Text] [Related]
44. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622 [TBL] [Abstract][Full Text] [Related]
45. Hypophosphatemic rickets: still misdiagnosed and inadequately treated. Greene WB; Kahler SG South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152 [TBL] [Abstract][Full Text] [Related]
46. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657 [TBL] [Abstract][Full Text] [Related]
47. A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet. Raeder H; Shaw N; Netelenbos C; Bjerknes R Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S101-5. PubMed ID: 18775977 [TBL] [Abstract][Full Text] [Related]
48. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets. Loeffler RD; Sherman FC Clin Orthop Relat Res; 1982; (162):4-10. PubMed ID: 6279346 [TBL] [Abstract][Full Text] [Related]
49. Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Kruse K; Hinkel GK; Griefahn B Eur J Pediatr; 1998 Nov; 157(11):894-900. PubMed ID: 9835432 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Drezner MK; Lyles KW; Haussler MR; Harrelson JM J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520 [TBL] [Abstract][Full Text] [Related]
52. [Treatment with 1,25-dihydroxycholecalciferol in children with different types of resistant rickets]. Eggers M; Beas F Rev Chil Pediatr; 1982; 53(2):95-101. PubMed ID: 6294757 [No Abstract] [Full Text] [Related]
53. Growth and metabolic control during puberty in girls with X-linked hypophosphataemic rickets. Sochett E; Doria AS; Henriques F; Kooh SW; Daneman A; Mäkitie O Horm Res; 2004; 61(5):252-6. PubMed ID: 15031616 [TBL] [Abstract][Full Text] [Related]
54. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
55. The efficacy and safety of different doses of calcitriol combined with neutral phosphate in X-linked hypophosphatemia: a prospective study. Jin C; Zhang C; Ni X; Zhao Z; Xu L; Wu B; Chi Y; Jiajue R; Jiang Y; Wang O; Li M; Xing X; Meng X; Xia W Osteoporos Int; 2022 Jun; 33(6):1385-1395. PubMed ID: 35088103 [TBL] [Abstract][Full Text] [Related]
56. Hypophosphataemic rickets: final height and clinical symptoms in adults. Stickler GB; Morgenstern BZ Lancet; 1989 Oct; 2(8668):902-5. PubMed ID: 2571821 [TBL] [Abstract][Full Text] [Related]